These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 7868152)

  • 81. B cell tolerance to xenoantigens.
    Ohdan H; Sykes M
    Xenotransplantation; 2003 Mar; 10(2):98-106. PubMed ID: 12588643
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Removal of xenoreactive human anti-pig antibodies by absorption on recombinant mucin-containing glycoproteins carrying the Gal alpha1,3Gal epitope.
    Liu J; Qian Y; Holgersson J
    Transplantation; 1997 Jun; 63(11):1673-82. PubMed ID: 9197365
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Complement activation, its consequences, and blockade by gene transfer.
    Carrington CA; Richards AC; van den Bogaerde J; Tucker AW; White DJ
    World J Surg; 1997; 21(9):907-12. PubMed ID: 9361503
    [TBL] [Abstract][Full Text] [Related]  

  • 84. A new in vitro model for the study of pig-to-human vascular hyperacute rejection.
    Bennet W; Sundberg B; Elgue G; Larsson R; Korsgren O; Nilsson B
    Xenotransplantation; 2001 Aug; 8(3):176-84. PubMed ID: 11472625
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Spectrum of the early xenograft response: from hyperacute rejection to delayed xenograft injury.
    Ierino FL; Sandrin MS
    Crit Rev Immunol; 2007; 27(2):153-66. PubMed ID: 17725501
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Prolonged discordant xenograft survival and delayed xenograft rejection in a pig-to-baboon orthotopic cardiac xenograft model.
    Xu H; Gundry SR; Hancock WW; Matsumiya G; Zuppan CW; Morimoto T; Slater J; Bailey LL
    J Thorac Cardiovasc Surg; 1998 Jun; 115(6):1342-9. PubMed ID: 9628677
    [TBL] [Abstract][Full Text] [Related]  

  • 87. IgY antiporcine endothelial cell antibodies effectively block human antiporcine xenoantibody binding.
    Fryer J; Firca J; Leventhal J; Blondin B; Malcolm A; Ivancic D; Gandhi R; Shah A; Pao W; Abecassis M; Kaufman D; Stuart F; Anderson B
    Xenotransplantation; 1999 May; 6(2):98-109. PubMed ID: 10431786
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Pig kidney transplantation in baboons: anti-Gal(alpha)1-3Gal IgM alone is associated with acute humoral xenograft rejection and disseminated intravascular coagulation.
    Bühler L; Yamada K; Kitamura H; Alwayn IP; Basker M; Appel JZ; Colvin RB; White-Scharf ME; Sachs DH; Robson SC; Awwad M; Cooper DK
    Transplantation; 2001 Dec; 72(11):1743-52. PubMed ID: 11740383
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Depletion of IgM xenoreactive natural antibodies by injection of anti-mu monoclonal antibodies.
    Latinne D; Soares M; Havaux X; Cormont F; Lesnikoski B; Bach FH; Bazin H
    Immunol Rev; 1994 Oct; 141():95-125. PubMed ID: 7868159
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Recent advances and the potential for clinical use of xenotransplantation.
    Minanov OP; Itescu S; Michler RE
    Curr Opin Cardiol; 1996 Mar; 11(2):214-20. PubMed ID: 8736694
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Different membrane cofactor protein (CD46) isoforms protect transfected cells against antibody and complement mediated lysis.
    Loveland BE; Johnstone RW; Russell SM; Thorley BR; McKenzie IF
    Transpl Immunol; 1993; 1(2):101-8. PubMed ID: 8081768
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The emergence of xenotransplantation.
    Fryer JP; Leventhal JR; Matas AJ
    Transpl Immunol; 1995 Mar; 3(1):21-31. PubMed ID: 7551975
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The complement system in xenotransplantation.
    Dalmasso AP
    Immunopharmacology; 1992; 24(2):149-60. PubMed ID: 1473965
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The promise of xenografting.
    Hanaway MJ; Platt JL
    Adv Ren Replace Ther; 1998 Oct; 5(4):299-308. PubMed ID: 9792085
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Accommodation in allogeneic and xenogeneic organ transplantation: Prevalence, impact, and implications for monitoring and for therapeutics.
    Platt JL; Cascalho M
    Hum Immunol; 2023 Jan; 84(1):5-17. PubMed ID: 36244871
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Xenoreactive natural antibodies.
    Bracy JL; Cretin N; Cooper DK; Iacomini J
    Cell Mol Life Sci; 1999 Dec; 56(11-12):1001-7. PubMed ID: 11212318
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The immunological hurdles to cardiac xenotransplantation.
    Platt JL
    J Card Surg; 2001; 16(6):439-47. PubMed ID: 11925024
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Disordered regulation of coagulation and platelet activation in xenotransplantation.
    Robson SC; Cooper DK; d'Apice AJ
    Xenotransplantation; 2000 Aug; 7(3):166-76. PubMed ID: 11021661
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The biological basis of and strategies for clinical xenotransplantation.
    Starzl TE; Valdivia LA; Murase N; Demetris AJ; Fontes P; Rao AS; Manez R; Marino IR; Todo S; Thomson AW
    Immunol Rev; 1994 Oct; 141():213-44. PubMed ID: 7868154
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Activation of human prothrombin by porcine aortic endothelial cells--a potential barrier to pig to human xenotransplantation.
    Jurd KM; Gibbs RV; Hunt BJ
    Blood Coagul Fibrinolysis; 1996 Apr; 7(3):336-43. PubMed ID: 8735141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.